Pancreatic Ductal Adenocarcinoma Contains an Effector and Regulatory Immune Cell Infiltrate that Is Altered by Multimodal Neoadjuvant Treatment

Pancreatic Ductal Adenocarcinoma Contains an Effector and Regulatory Immune Cell Infiltrate that Is Altered by Multimodal Neoadjuvant Treatment

Bibliographic Details
Main Authors:	Shibuya, Kendall C., Goel, Vikas K., Xiong, Wei, Sham, Jonathan G., Pollack, Seth M., Leahy, Allison M., Whiting, Samuel H., Yeh, Matthew M., Yee, Cassian, Riddell, Stanley R., Pillarisetty, Venu G.
Format:	Online
Language:	English
Published:	Public Library of Science 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008589/

Similar Items

The pancreatic cancer microenvironment: an immunologic battleground
by: Pillarisetty, Venu G
Published: (2014)

The imaging and pathological features of metastatic leiomyosarcoma in the gallbladder
by: Yi Guo, et al.
Published: (2016-12-01)

Inflammatory infiltrate in invasive lobular and ductal carcinoma of the breast.
by: Lee, A. H., et al.
Published: (1996)

Association of Pancreatic Fatty Infiltration With Pancreatic Ductal Adenocarcinoma
by: Hori, Mika, et al.
Published: (2014)

CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast
by: Rathore, Ankita Singh, et al.
Published: (2014)

An Evaluation of Neoadjuvant Chemoradiotherapy for Patients with Resectable Pancreatic Ductal Adenocarcinoma
by: Jiang, Hui, et al.
Published: (2013)

Adjuvant, neoadjuvant, and experimental regimens in overcoming pancreatic ductal adenocarcinoma
by: Wysocka, Olga, et al.
Published: (2016)

Tetramer guided, cell sorter assisted production of clinical grade autologous NY-ESO-1 specific CD8+ T cells
by: Pollack, Seth M, et al.
Published: (2014)

Differences in Response and Surgical Management with Neoadjuvant Chemotherapy in Invasive Lobular Versus Ductal Breast Cancer
by: Truin, W., et al.
Published: (2015)

Infiltrating ductal carcinoma breast with central necrosis closely mimicking ductal carcinoma in situ (comedo type): a case series
by: Pervez, Shahid, et al.
Published: (2007)

Prognostic significance of tumor-infiltrating lymphocytes in ductal carcinoma in situ of the breast
by: Toss, Michael S., et al.
Published: (2018)

Infiltrating Ductal Carcinoma of the Breast Associated with Primary Breast Lymphoma
by: Arlen, Myron, et al.
Published: (2011)

Identification Of Biomarkers In Infiltrating Ductal Carcinoma: A Proteomics Approach
by: Seng , Liang
Published: (2009)

Infiltrating Ductal Carcinoma of the Breast Associated with Primary Breast Lymphoma
by: Myron Arlen, Jacob J. Freiman, Marina Ionescu
Published: (2011-01-01)

Tumor infiltrating lymphocytes in triple negative breast cancer receiving neoadjuvant chemotherapy
by: Castaneda, Carlos A, et al.
Published: (2016)

Metastatic Infiltrating Ductal Carcinoma of the Breast to the Colon: A Case Report and Literature Review
by: Samo, Salih, et al.
Published: (2013)

Expression of γH2AX may help in defining a genetically more stable subtype of infiltrating ductal carcinoma of breast
by: Bhatia, Alka, et al.
Published: (2013)

PB.40. What happens to the ductal carcinoma in situ in HER2-positive cancers treated with neoadjuvant chemotherapy and trastuzumab?
by: Millican-Slater, R, et al.
Published: (2014)

Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas
by: Delpech, Y, et al.
Published: (2013)

The presence of lymphovascular and perineural infiltration after neoadjuvant therapy and oesophagectomy identifies patients at high risk for recurrence
by: Lagarde, S M, et al.
Published: (2015)

A case of pancreatic ductal adenocarcinoma with marked infiltration with IgG4-positive cells
by: Yoneda, M, et al.
Published: (2013)

A new cell line (8701-BC) from primary ductal infiltrating carcinoma of human breast.
by: Minafra, S., et al.
Published: (1989)

Prospective Validation of Immunological Infiltrate for Prediction of Response to Neoadjuvant Chemotherapy in HER2-Negative Breast Cancer – A Substudy of the Neoadjuvant GeparQuinto Trial
by: Issa-Nummer, Yasmin, et al.
Published: (2013)

Isolated eosinophilic infiltration of the breast
by: Parakh, Anushri, et al.
Published: (2016)

CD8+ tumor‐infiltrating lymphocytes contribute to spontaneous “healing” in HER2‐positive ductal carcinoma in situ
by: Morita, Michi, et al.
Published: (2016)

Novel approaches in the management of pancreatic ductal adenocarcinoma: potential promises for the future
by: Goel, Gaurav, et al.
Published: (2015)

Clinicopathologic characteristics at diagnosis and the survival of patients with medullary breast carcinoma in China: a comparison with infiltrating ductal carcinoma-not otherwise specified
by: Cao, A-Yong, et al.
Published: (2013)

Tumor characteristics and the clinical outcome of invasive lobular carcinoma compared to infiltrating ductal carcinoma in a Chinese population
by: Cao, A-Yong, et al.
Published: (2012)

Detection of serum VEGF and MMP-9 levels by Luminex multiplexed assays in patients with breast infiltrative ductal carcinoma
by: ZHANG, JUNYING, et al.
Published: (2014)

An Increased Abundance of Tumor-Infiltrating Regulatory T Cells Is Correlated with the Progression and Prognosis of Pancreatic Ductal Adenocarcinoma
by: Tang, Yichen, et al.
Published: (2014)

Pituitary Tumor-Transforming Gene 1 Is Expressed in Primary Ductal Breast Carcinoma, Lymph Node Infiltration, and Distant Metastases
by: Grizzi, Fabio, et al.
Published: (2013)

CD44 expression and axillary lymph node metastasis in infiltrating ductal carcinoma of the breast
by: ZAINAB BINTI AWANG NGAH
Published: (2006)

Solitary adrenal metastasis from invasive infiltrating ductal carcinoma: A case report and review of literature
by: Nor Fathihah binti Mamat
Published: (2013)

The Major Prognostic Features of Nuclear Receptor NR5A2 in Infiltrating Ductal Breast Carcinomas
by: Chang, Li-Yun, et al.
Published: (2015)

Long-term Survival after Resection of HER2+ Infiltrating Ductal Carcinoma Metastasis to the Brainstem
by: Awad, Al-Wala, et al.
Published: (2016)

Phenotype, function and T cell receptor repertoire of tumor-infiltrating lymphocytes in patients with pancreatic ductal adenocarcinoma
by: Poschke, Isabel, et al.
Published: (2015)

Infiltrating ductal carcinoma breast, metastatic to ipsilateral axillary lymph nodes harbouring primary tuberculous lymphadenitis: a case report
by: Pandey, Pinki, et al.
Published: (2014)

CA15.3 Serum Concentrations in Older Women with Infiltrating Ductal Carcinomas of the Breast
by: Ruibal, Álvaro, et al.
Published: (2014)

Clinicopathological significance of CD133 and CD44 expression in infiltrating ductal carcinoma and their relationship to angiogenesis
by: Han, Zhengquan, et al.
Published: (2015)

Recognition of dose infiltration on pulmonary ventilation-perfusion scintigraphy
by: Goel, Sumina, et al.
Published: (2015)